174 related articles for article (PubMed ID: 34316712)
1. Analysis of gene expression and mutation data points on contribution of transcription to the mutagenesis by APOBEC enzymes.
Chervova A; Fatykhov B; Koblov A; Shvarov E; Preobrazhenskaya J; Vinogradov D; Ponomarev GV; Gelfand MS; Kazanov MD
NAR Cancer; 2021 Sep; 3(3):zcab025. PubMed ID: 34316712
[TBL] [Abstract][Full Text] [Related]
2. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
[TBL] [Abstract][Full Text] [Related]
3. APOBEC mutagenesis is low in most types of non-B DNA structures.
Ponomarev GV; Fatykhov B; Nazarov VA; Abasov R; Shvarov E; Landik NV; Denisova AA; Chervova AA; Gelfand MS; Kazanov MD
iScience; 2022 Jul; 25(7):104535. PubMed ID: 35754742
[TBL] [Abstract][Full Text] [Related]
4. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
5. APOBEC-Induced Cancer Mutations Are Uniquely Enriched in Early-Replicating, Gene-Dense, and Active Chromatin Regions.
Kazanov MD; Roberts SA; Polak P; Stamatoyannopoulos J; Klimczak LJ; Gordenin DA; Sunyaev SR
Cell Rep; 2015 Nov; 13(6):1103-1109. PubMed ID: 26527001
[TBL] [Abstract][Full Text] [Related]
6. Genetic modifiers of APOBEC-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Bray N; Mitchell D; Lobachev K; Roberts SA
bioRxiv; 2023 Apr; ():. PubMed ID: 37066362
[TBL] [Abstract][Full Text] [Related]
7. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
[TBL] [Abstract][Full Text] [Related]
8. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
9. Breaking bad: The mutagenic effect of DNA repair.
Chen J; Furano AV
DNA Repair (Amst); 2015 Aug; 32():43-51. PubMed ID: 26073774
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing.
Sakhtemani R; Senevirathne V; Stewart J; Perera MLW; Pique-Regi R; Lawrence MS; Bhagwat AS
J Biol Chem; 2019 Oct; 294(41):15037-15051. PubMed ID: 31431505
[TBL] [Abstract][Full Text] [Related]
11. Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature.
Nakauma-González JA; Rijnders M; Noordsij MTW; Martens JWM; van der Veldt AAM; Lolkema MPJ; Boormans JL; van de Werken HJG
Cell Genom; 2024 Apr; 4(4):100528. PubMed ID: 38552621
[TBL] [Abstract][Full Text] [Related]
12. KMT2C-deficient tumors have elevated APOBEC mutagenesis and genomic instability in multiple cancers.
Hu X; Biswas A; De S
NAR Cancer; 2022 Sep; 4(3):zcac023. PubMed ID: 35898555
[TBL] [Abstract][Full Text] [Related]
13. Analysis of APOBEC-induced mutations in yeast strains with low levels of replicative DNA polymerases.
Sui Y; Qi L; Zhang K; Saini N; Klimczak LJ; Sakofsky CJ; Gordenin DA; Petes TD; Zheng DQ
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9440-9450. PubMed ID: 32277034
[TBL] [Abstract][Full Text] [Related]
14. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
[TBL] [Abstract][Full Text] [Related]
15. APOBEC-Induced Mutagenesis in Cancer.
Mertz TM; Collins CD; Dennis M; Coxon M; Roberts SA
Annu Rev Genet; 2022 Nov; 56():229-252. PubMed ID: 36028227
[TBL] [Abstract][Full Text] [Related]
16. APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response.
Glaser AP; Fantini D; Wang Y; Yu Y; Rimar KJ; Podojil JR; Miller SD; Meeks JJ
Oncotarget; 2018 Jan; 9(4):4537-4548. PubMed ID: 29435122
[TBL] [Abstract][Full Text] [Related]
17. APOBEC Mutagenesis in Cancer Development and Susceptibility.
Dananberg A; Striepen J; Rozowsky JS; Petljak M
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254863
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
[TBL] [Abstract][Full Text] [Related]
19. Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.
Faden DL; Thomas S; Cantalupo PG; Agrawal N; Myers J; DeRisi J
Oral Oncol; 2017 Nov; 74():8-14. PubMed ID: 29103756
[TBL] [Abstract][Full Text] [Related]
20. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
